
MedGenome
Developer of sequencing genomics-based diagnostics and research platform intended for patients, pharmaceutical companies, and research institutions around the world. The company's platform applies gen...
Valuation
$603M
Latest known
Share Price
N/A
Total Raised
$222.9M
Last Round
N/A